Severe COVID-19 in inflammatory bowel disease patients in a population-based settingRob H. Creemers, Ad A. van Bodegraven, Mathie P.G. Leers et al.|PLoS ONE|2021Cited by 15
A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes to assess the pharmacodynamic effect of thiopurine therapy in Inflammatory Bowel Disease patientsDebbie S. Deben, Dennis R. Wong, Rob H. Creemers et al.|Scientific Reports|2022Cited by 3
P464 Rac1/pSTAT3 expression in T lymphocytes: A potential pharmacodynamic marker for thiopurines in the treatment of Inflammatory Bowel Disease patients?Debbie S. Deben, Dennis R. Wong, A Van Bodegraven et al.|Journal of Crohn s and Colitis|2022Cited by 0